CH-Bioforce Oy
PrivateLast Round
Grant
Jun 22, 2022
Total Funding Raised
$2.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CH-Bioforce Oy operates in Energy & Sustainability and is based in Espoo. Its latest recorded funding round was an Accelerator round in February 2020.
CH-Bioforce Oy is a cleantech company that has developed a biomass fractionation technology to convert waste streams into complete bio-based materials like cellulose, lignin, and hemicellulose.
Sector
Energy & Sustainability
Verticals
Sustainable Materials, Advanced Materials, Circular Economy, Clean Manufacturing, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CH-Bioforce Oy Comparables
Compare CH-Bioforce Oy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lixea | 90% | |
| Bloom Biorenewables | 84% | |
| CELLiCON | 84% |
For institutional investors. Book with your work email.
CH-Bioforce Oy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 22, 2022 | ||||
| Accelerator | Feb 27, 2020 | ||||
| Grant | Mar 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CH-Bioforce Oy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Innovation Council Fund | Grant |
| 100+ Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 43% MoM.
- Apr 18, 2026
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
CH-Bioforce Oy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CH-Bioforce Oy's valuation, stock price, and market status.
Is CH-Bioforce Oy a public or private company?
CH-Bioforce Oy is a private company.
What is the current stock price of CH-Bioforce Oy?
CH-Bioforce Oy is a private company, so its shares have no public market price. Caplight tracks CH-Bioforce Oy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CH-Bioforce Oy worth (valuation)?
Valuation information for CH-Bioforce Oy is not publicly available.
Can I buy CH-Bioforce Oy stock?
CH-Bioforce Oy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CH-Bioforce Oy's last funding round?
CH-Bioforce Oy's most recent funding round was Grant on June 22, 2022.
Who are the main investors in CH-Bioforce Oy?
Key investors in CH-Bioforce Oy include European Innovation Council Fund, 100+ Accelerator.
Will CH-Bioforce Oy IPO soon?
No public IPO plans have been announced for CH-Bioforce Oy.
How can I track CH-Bioforce Oy secondary market activity?
Caplight tracks bids, offers, and trades in CH-Bioforce Oy's shares on secondary markets.